vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and CPI Card Group Inc. (PMTS). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $153.1M, roughly 1.3× CPI Card Group Inc.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 4.8%, a 3.5% gap on every dollar of revenue. On growth, CPI Card Group Inc. posted the faster year-over-year revenue change (22.3% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $35.2M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 16.9%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
COLL vs PMTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $153.1M |
| Net Profit | $17.0M | $7.3M |
| Gross Margin | 62.5% | 31.5% |
| Operating Margin | 29.6% | 12.0% |
| Net Margin | 8.3% | 4.8% |
| Revenue YoY | 12.9% | 22.3% |
| Net Profit YoY | 35.3% | 8.5% |
| EPS (diluted) | $0.48 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $153.1M | ||
| Q3 25 | $209.4M | $138.0M | ||
| Q2 25 | $188.0M | $129.8M | ||
| Q1 25 | $177.8M | $122.8M | ||
| Q4 24 | $181.9M | $125.1M | ||
| Q3 24 | $159.3M | $124.8M | ||
| Q2 24 | $145.3M | $118.8M | ||
| Q1 24 | $144.9M | $111.9M |
| Q4 25 | $17.0M | $7.3M | ||
| Q3 25 | $31.5M | $2.3M | ||
| Q2 25 | $12.0M | $518.0K | ||
| Q1 25 | $2.4M | $4.8M | ||
| Q4 24 | $12.5M | $6.8M | ||
| Q3 24 | $9.3M | $1.3M | ||
| Q2 24 | $19.6M | $6.0M | ||
| Q1 24 | $27.7M | $5.5M |
| Q4 25 | 62.5% | 31.5% | ||
| Q3 25 | 61.7% | 29.7% | ||
| Q2 25 | 57.7% | 30.9% | ||
| Q1 25 | 54.8% | 33.2% | ||
| Q4 24 | 54.0% | 34.1% | ||
| Q3 24 | 60.8% | 35.8% | ||
| Q2 24 | 62.5% | 35.7% | ||
| Q1 24 | 63.1% | 37.1% |
| Q4 25 | 29.6% | 12.0% | ||
| Q3 25 | 29.7% | 9.4% | ||
| Q2 25 | 18.7% | 7.3% | ||
| Q1 25 | 12.2% | 11.5% | ||
| Q4 24 | 20.9% | 12.7% | ||
| Q3 24 | 21.9% | 14.3% | ||
| Q2 24 | 32.7% | 12.5% | ||
| Q1 24 | 34.1% | 12.6% |
| Q4 25 | 8.3% | 4.8% | ||
| Q3 25 | 15.0% | 1.7% | ||
| Q2 25 | 6.4% | 0.4% | ||
| Q1 25 | 1.4% | 3.9% | ||
| Q4 24 | 6.9% | 5.4% | ||
| Q3 24 | 5.9% | 1.0% | ||
| Q2 24 | 13.5% | 5.1% | ||
| Q1 24 | 19.1% | 4.9% |
| Q4 25 | $0.48 | $0.62 | ||
| Q3 25 | $0.84 | $0.19 | ||
| Q2 25 | $0.34 | $0.04 | ||
| Q1 25 | $0.07 | $0.40 | ||
| Q4 24 | $0.36 | $0.56 | ||
| Q3 24 | $0.27 | $0.11 | ||
| Q2 24 | $0.52 | $0.51 | ||
| Q1 24 | $0.71 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $21.7M |
| Total DebtLower is stronger | — | $286.7M |
| Stockholders' EquityBook value | $301.7M | $-17.3M |
| Total Assets | $1.7B | $403.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $21.7M | ||
| Q3 25 | $285.9M | $16.0M | ||
| Q2 25 | $222.2M | $17.1M | ||
| Q1 25 | $197.8M | $31.5M | ||
| Q4 24 | $162.8M | $33.5M | ||
| Q3 24 | $120.0M | $14.7M | ||
| Q2 24 | $271.6M | $7.5M | ||
| Q1 24 | $318.0M | $17.1M |
| Q4 25 | — | $286.7M | ||
| Q3 25 | — | $308.4M | ||
| Q2 25 | — | $310.9M | ||
| Q1 25 | — | $280.7M | ||
| Q4 24 | — | $280.4M | ||
| Q3 24 | — | $280.2M | ||
| Q2 24 | — | $269.7M | ||
| Q1 24 | — | $265.3M |
| Q4 25 | $301.7M | $-17.3M | ||
| Q3 25 | $274.8M | $-25.7M | ||
| Q2 25 | $232.2M | $-29.0M | ||
| Q1 25 | $234.4M | $-29.7M | ||
| Q4 24 | $228.8M | $-35.6M | ||
| Q3 24 | $234.3M | $-42.8M | ||
| Q2 24 | $216.6M | $-44.6M | ||
| Q1 24 | $222.2M | $-48.5M |
| Q4 25 | $1.7B | $403.2M | ||
| Q3 25 | $1.6B | $407.1M | ||
| Q2 25 | $1.6B | $399.8M | ||
| Q1 25 | $1.6B | $351.9M | ||
| Q4 24 | $1.7B | $349.7M | ||
| Q3 24 | $1.6B | $342.3M | ||
| Q2 24 | $1.1B | $321.4M | ||
| Q1 24 | $1.1B | $319.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $39.6M |
| Free Cash FlowOCF − Capex | $122.4M | $35.2M |
| FCF MarginFCF / Revenue | 59.6% | 23.0% |
| Capex IntensityCapex / Revenue | 0.3% | 2.9% |
| Cash ConversionOCF / Net Profit | 7.25× | 5.39× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $41.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $39.6M | ||
| Q3 25 | $78.4M | $10.0M | ||
| Q2 25 | $72.4M | $4.3M | ||
| Q1 25 | $55.4M | $5.6M | ||
| Q4 24 | $84.6M | $26.7M | ||
| Q3 24 | $-9.0M | $12.5M | ||
| Q2 24 | $67.4M | $-4.8M | ||
| Q1 24 | $61.9M | $8.9M |
| Q4 25 | $122.4M | $35.2M | ||
| Q3 25 | $78.3M | $5.3M | ||
| Q2 25 | $72.4M | $533.0K | ||
| Q1 25 | $54.6M | $292.0K | ||
| Q4 24 | $84.1M | $21.6M | ||
| Q3 24 | $-9.2M | $11.1M | ||
| Q2 24 | $67.1M | $-6.0M | ||
| Q1 24 | $61.4M | $7.4M |
| Q4 25 | 59.6% | 23.0% | ||
| Q3 25 | 37.4% | 3.8% | ||
| Q2 25 | 38.5% | 0.4% | ||
| Q1 25 | 30.7% | 0.2% | ||
| Q4 24 | 46.2% | 17.3% | ||
| Q3 24 | -5.8% | 8.9% | ||
| Q2 24 | 46.2% | -5.0% | ||
| Q1 24 | 42.3% | 6.6% |
| Q4 25 | 0.3% | 2.9% | ||
| Q3 25 | 0.1% | 3.4% | ||
| Q2 25 | 0.0% | 2.9% | ||
| Q1 25 | 0.4% | 4.3% | ||
| Q4 24 | 0.3% | 4.0% | ||
| Q3 24 | 0.2% | 1.2% | ||
| Q2 24 | 0.2% | 1.0% | ||
| Q1 24 | 0.4% | 1.3% |
| Q4 25 | 7.25× | 5.39× | ||
| Q3 25 | 2.49× | 4.32× | ||
| Q2 25 | 6.05× | 8.39× | ||
| Q1 25 | 22.92× | 1.17× | ||
| Q4 24 | 6.75× | 3.94× | ||
| Q3 24 | -0.96× | 9.70× | ||
| Q2 24 | 3.44× | -0.79× | ||
| Q1 24 | 2.23× | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
